长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00775 长江生命科技

未开盘 10-22 16:08:33

0.495

-0.010

-1.98%

最高0.510	最低0.495	成交量353.00万
今开0.505	昨收0.505	日振幅2.97%
总市值47.57亿	流通市值47.57亿	总股本96.11亿
成交额176.55万	换手率0.04%	流通股本96.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00775","market":"HK","secType":"STK","nameCN":"长江生命科技","latestPrice":0.495,"timestamp":1792656513799,"preClose":0.505,"halted":0,"volume":3530000,"delay":0,"changeRate":-0.01980198019801982,"floatShares":9611072400,"shares":9611072400,"eps":-0.0194,"marketStatus":"未开盘","change":-0.01,"latestTime":"10-22 16:08:33","open":0.505,"high":0.51,"low":0.495,"amount":1765460,"amplitude":0.029703,"askPrice":0.495,"askSize":22000,"bidPrice":0.49,"bidSize":354000,"shortable":3,"etf":0,"ttmEps":-0.006742,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792719000000},"marketStatusCode":0,"adr":0,"listingDate":1026748800000,"exchange":"SEHK","adjPreClose":0.505,"openAndCloseTimeList":[[1792632600000,1792641600000],[1792645200000,1792656000000]],"volumeRatio":3.3314458285202497,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00775","defaultTab":"news","newsList":[{"id":"1153272018","title":"长江生命科技9月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1153272018","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153272018?lang=zh_cn&edition=full","pubTime":"2026-10-05 17:35","pubTimestamp":1791192947,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年10月5日发布了截至2026年9月30日的最新证券变动月报。报告显示，长江生命科技在本月度并无新增发行或库藏股回购等活动，股本结构保持稳定。本次月报披露，截至2026年9月30日，长江生命科技的法定/注册股本仍为150亿股，面值每股0.1港元，总额15亿港元，与上月底结存持平。长江生命科技表示将继续遵守香港联交所《上市规则》及相关法律法规，公告由公司秘书杨逸芝签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196848311","title":"长江生命科技2026年8月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1196848311","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196848311?lang=zh_cn&edition=full","pubTime":"2026-09-02 16:40","pubTimestamp":1788338404,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年9月2日发布月度权益变动报告，报告期为2026年8月1日至8月31日。根据公告，截至2026年8月31日，公司已发行股份总数为9,611,072,400股，与上月底持平，库存股份数目仍为0股。公告显示，报告期内普通股的法定/注册股本数目依旧为15,000,000,000股，每股面值为0.10港元，合计注册股本为1,500,000,000港元。截至2026年8月31日，公司股本结构维持稳定，未有股份发行及回购活动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658999985","title":"长江生命科技：上半财年营收27.16亿港元，同比增长4.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658999985","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658999985?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:44","pubTimestamp":1786441440,"startTime":"0","endTime":"0","summary":"南财智讯8月11日电，长江生命科技（00775.HK）公告，截至2026年6月30日止六个月实现营业收入27.16亿港元，同比增长4.22%；上年同期为26.06亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608113837978836.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608113837978836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996739","title":"长江生命科技(00775)发布中期业绩，股东应占亏损2873万港元 同比减少80.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996739","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996739?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:40","pubTimestamp":1786441207,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技 发布2026年中期业绩，该集团取得收入27.16亿港元，同比增加4.22%;公司股东权益应占亏损2873万港元，同比减少80.95%;每股亏损0.3港仙。该重组涉及美国纳斯达克上市公司TransCode Therapeutics收购长江生命科技旗下从事研发的附属公司 Polynoma。根据交易安排，长江生命科技预期将成为RNAZ的主要股东。此项会计处理变动令回顾期内的研发开支大幅减少，取得的亏损遂相应较去年为少。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1569","00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180682707","title":"长江生命科技7月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1180682707","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180682707?lang=zh_cn&edition=full","pubTime":"2026-08-04 18:41","pubTimestamp":1785840099,"startTime":"0","endTime":"0","summary":"2026年8月4日，长江生命科技集团有限公司公布了截至2026年7月31日止月份的股份变动月报数据显示，期内未新增发行或回购股份。已发行普通股数为9,611,072,400股，库藏股数量为0股，较上月无变化。根据公告，公司于7月末继续满足香港联交所上市规则有关公众持股量的要求，股本结构保持稳定。本月无新增股份期权或股权激励计划变动，也无任何可换股票据或其他授予发行股份的协议。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185090631","title":"长江生命科技(00775)定于8月11日召开董事会审议2026年中期业绩及分红","url":"https://stock-news.laohu8.com/highlight/detail?id=1185090631","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185090631?lang=zh_cn&edition=full","pubTime":"2026-07-30 17:35","pubTimestamp":1785404153,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司（00775）7月30日公告称，公司董事会将于2026年8月11日（星期二）在香港召开会议。董事会将审议并批准截至2026年6月30日止六个月的中期业绩，同时考虑派发中期股息。\n公告显示，公司现任执行董事包括李泽钜、甘庆林、叶德铨、余英才及杜健明；非执行董事为Peter Peace Tulloch；独立非执行董事为郭李绮华、关启昌、Paul Joseph Tighe及罗弼士。\n公司秘书杨逸芝代表董事会签署了本次公告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179835584","title":"长江生命科技更新6月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1179835584","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179835584?lang=zh_cn&edition=full","pubTime":"2026-07-03 18:51","pubTimestamp":1783075897,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年7月3日发布截至2026年6月30日止的股份变动月报表，公告其当月股本结构及变动信息。公告显示，公司法定股本本月底维持在15,000,000,000股，每股面值0.1港元，合计股本为港币1,500,000,000，与上月底一致。普通股已发行股本总数为9,611,072,400股，库藏股份数量保持为0股，报告期内无新增发行、购回、注销或任何其他股份变动。本次公告由公司秘书杨逸芝签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184272208","title":"长江生命科技更新5月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1184272208","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184272208?lang=zh_cn&edition=full","pubTime":"2026-06-02 16:36","pubTimestamp":1780389362,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于2026年6月2日披露了截至2026年5月31日的证券变动月报表。报告期内，公司法定股本和已发行股份情况保持稳定。公司本月内无新增股份发行、购回、注销或库藏股行为。公告同时指出，长江生命科技确认其已满足香港联合交易所有限公司股份上市规定所要求的公眾持股量门槛，适用的公眾持股量要求为不低于发行在外股份总数的25%。本次月报由公司秘书杨逸芝签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199724940","title":"长江生命科技高层变动：李源辞任执行董事、副总裁兼首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=1199724940","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199724940?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:38","pubTimestamp":1778247493,"startTime":"0","endTime":"0","summary":"长江生命科技国际有限公司宣布，李源（Lance Richard Lee Yuen）已辞去公司执行董事、副总裁及首席执行官职务。此次人事变动即刻生效，标志着公司管理层迎来重要调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","00775","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633454462","title":"长江生命科技(00775)：Lance Richard Lee Yuen辞任执行董事、副总裁及行政总监","url":"https://stock-news.laohu8.com/highlight/detail?id=2633454462","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633454462?lang=zh_cn&edition=full","pubTime":"2026-05-08 21:38","pubTimestamp":1778247492,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技(00775)公布，Lance Richard Lee Yuen先生自2026年5月8日起辞任公司执行董事、副总裁及行政总监，惟将继续担任公司加拿大附属公司的董事，负责监督当地业务。此外，执行董事余英才先生自2026年5月8日起，由现任公司副主席调任为副主席及行政总监。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00775","BK1161","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157997333","title":"长江生命科技2026年4月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1157997333","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157997333?lang=zh_cn&edition=full","pubTime":"2026-05-05 17:06","pubTimestamp":1777971994,"startTime":"0","endTime":"0","summary":"长江生命科技（股票代码：00775）近日发布截至2026年4月30日止的月报表并于2026年5月5日提交。公告显示，公司法定注册股本数目为15,000,000,000股，每股面值为0.1港元，合计注册股本金约15亿港元，较上月无变化。\n公司已发行股份数目期末余额为9,611,072,400股，无库存股份，与上月保持一致。报告期内，公司并未进行任何股份发行、购回或注销，也无股份期权、权证及可换股票据的授出或行使，股本结构整体维持稳定。\n公司确认，截至2026年4月30日，符合香港联交所相关上市规则关于公众持股量的要求。本次公告由公司秘书杨逸芝于2026年5月5日签署并提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148808097","title":"长江生命科技2025年度：科研投入加大，多元业务结构呈现新变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1148808097","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148808097?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:45","pubTimestamp":1776415559,"startTime":"0","endTime":"0","summary":"长江生命科技于报告期内整体业绩由盈转亏，年度亏损约1.88亿元，而上年度亏损约1.27亿元。公司方面指出，受全球经济复苏节奏、研发支出增加及市场竞争等多重因素影响，报告期利润水平出现显著下滑，不过综合全面收益则因资产重估及汇兑因素而实现一定回升。在主营生命科技与医药研发板块，公司年内持续推动针对RNA疗法、免疫疗法及神经性疼痛等领域的管线项目。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130216431","title":"长江生命科技拟回购最多10%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1130216431","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130216431?lang=zh_cn&edition=full","pubTime":"2026-04-17 16:41","pubTimestamp":1776415283,"startTime":"0","endTime":"0","summary":"长江生命科技集团有限公司于近日在公告中披露，董事会将于2026年5月21日举行股东周年大会，以寻求授权回购不超过公司当日已发行股份总数10%的股份。根据公告，长江生命科技过去十二个月股价最高曾达每股1.10港元，最低曾见每股0.45港元。公告同时提及，股东周年大会预计于5月21日上午9时在香港及网上进行，并将就上述授权进行表决。董事会声明，此举符合公司及全体股东的整体最佳利益。该计划最终能否落实尚需获得股东大会的批准。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518212613","title":"长江生命科技03月10日获主力加仓2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518212613","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518212613?lang=zh_cn&edition=full","pubTime":"2025-03-10 16:17","pubTimestamp":1741594656,"startTime":"0","endTime":"0","summary":"03月10日，长江生命科技股价收平报0.55元，成交金额355万元，换手率0.07%，振幅3.64%，量比0.72。长江生命科技今日主力资金净流入2万元，上一交易日主力净流入350万元。该股近5个交易日上涨11.11%，主力资金累计净流入312万元；近20日主力资金累计净流入240万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310171014a269bf1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310171014a269bf1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","00775","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517103075","title":"长江生命科技03月07日主力净流入350万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2517103075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517103075?lang=zh_cn&edition=full","pubTime":"2025-03-07 16:16","pubTimestamp":1741335398,"startTime":"0","endTime":"0","summary":"03月07日, 长江生命科技股价涨1.85%，报收0.55元，成交金额1499万元，换手率0.29%，振幅14.81%，量比7.47。长江生命科技今日主力资金净流入350万元，上一交易日主力净流出0万元。该股近5个交易日上涨10.00%，主力资金累计净流入310万元；近20日主力资金累计净流入203万元，其中净流入天数为4日。该股主力净额占比0.07%，港股市场排名127/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170648abecc897&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307170648abecc897&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517140809","title":"长和(00001)盘初一度跌逾3% 旗下长江生命科技(00775)去年盈转亏1.3亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517140809","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517140809?lang=zh_cn&edition=full","pubTime":"2025-03-07 10:32","pubTimestamp":1741314779,"startTime":"0","endTime":"0","summary":"金吾财讯 | 长和(00001)盘初一度跌逾3%，截至发稿，跌2.23%，报50.4港元，成交额9.09亿港元。消息面上，长和旗下长江生命科技(00775)发盈警，预期截至2024年12月31日止报告年度录得港币1.3亿元股东应占亏损，对比截至2023年12月31日止年度，股东应占溢利为港币1730万元。应占溢利转盈为亏乃归因于公司决意增加研发投资，以及葡萄园组合的公平值下降。整体而言，集团的营运于报告年度及截至公告日期一直维持稳定。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1954569","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00775","00001","BK1521","LU1048588211.SGD","BK1601","BK1161","BK1230","LU0072462343.USD","IE0032431581.USD","BK1500","BK1569","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517413971","title":"长江生命科技盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517413971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517413971?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:31","pubTimestamp":1741311061,"startTime":"0","endTime":"0","summary":"2025年03月07日早盘09时31分，长江生命科技股票出现异动，股价大幅下挫5.56%。截至发稿，该股报0.510港元/股，成交量86.2万股，换手率0.01%，振幅3.70%。长江生命科技股票所在的药品行业中，整体涨幅为0.02%。其相关个股中，兴科蓉医药、联邦制药、白花油涨幅较大，振幅较大的相关个股有长江生命科技、信达生物、绿叶制药，振幅分别为3.70%、2.35%、2.07%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307093101989f359f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307093101989f359f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","00775","BK1569"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517016583","title":"长江生命科技(00775)发盈警，预期年度股东应占亏损1.266亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2517016583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517016583?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:37","pubTimestamp":1741271846,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长江生命科技(00775)发布公告，本集团预期截至2024年12月31日止年度(报告年度)取得1.266亿元股东应占亏损，对比截至2023年12月31日止年度，股东应占溢利为1730万元。是次应占溢利转盈为亏乃归因于本公司决意增加研发投资，以及葡萄园组合的公平值下降。整体而言，本集团的营运于报告年度及截至本公告日期一直维持稳定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1569","00775","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517901385","title":"长江生命科技盘中异动 临近午盘股价大涨6.00%报0.530港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517901385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517901385?lang=zh_cn&edition=full","pubTime":"2025-03-06 11:57","pubTimestamp":1741233435,"startTime":"0","endTime":"0","summary":"2025年03月06日临近午盘11时57分，长江生命科技股票出现波动，股价急速上涨6.00%。截至发稿，该股报0.530港元/股，成交量402.8万股，换手率0.04%，振幅6.00%。资金方面，该股资金流入158.5万港元，流出39.456万港元。长江生命科技股票所在的药品行业中，整体涨幅为0.14%。长江生命科技公司简介：长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306115715abeaaa5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306115715abeaaa5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00775","BK1569","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512054146","title":"长江生命科技盘中异动 大幅拉升5.05%报0.520港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512054146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512054146?lang=zh_cn&edition=full","pubTime":"2025-02-19 10:32","pubTimestamp":1739932367,"startTime":"0","endTime":"0","summary":"2025年02月19日早盘10时32分，长江生命科技股票出现异动，股价大幅上涨5.05%。截至发稿，该股报0.520港元/股，成交量166.4万股，换手率0.02%，振幅5.05%。资金方面，该股资金流入53.572万港元，流出30.137万港元。长江生命科技股票所在的药品行业中，整体涨幅为0.01%。其相关个股中，德琪医药-B、兴科蓉医药、中国医疗集团涨幅较大，振幅较大的相关个股有顺腾国际控股、德琪医药-B、李氏大药厂，振幅分别为23.08%、12.95%、9.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219103247abd44d37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219103247abd44d37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1569","00775","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ck-lifesciences.com","stockEarnings":[{"period":"1week","weight":-0.0294},{"period":"1month","weight":-0.0917},{"period":"3month","weight":-0.1316},{"period":"6month","weight":-0.3219},{"period":"1year","weight":-0.4438},{"period":"ytd","weight":-0.3963}],"compareEarnings":[{"period":"1week","weight":-0.0469},{"period":"1month","weight":-0.0858},{"period":"3month","weight":-0.0813},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.1104},{"period":"ytd","weight":-0.1052}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长江生命科技集团有限公司是一家主要从事健康产品研发及销售业务的投资控股公司。该公司主要从事保健产品及医药产品的研发、生产、推广及销售等人类健康业务。该公司旗下保健产品品牌包括Lipa，Vitaquest以及Sante Naturelle等。其研发药物产品主要包括癌症相关药物及止痛药物等。农业相关业务分部经营葡萄园以及研发、生产、推广及销售农业及相关产品。其农业产品包括肥料产品及植物保护产品等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.015869},{"month":2,"riseRate":0.458333,"avgChangeRate":0.029716},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.079623},{"month":4,"riseRate":0.625,"avgChangeRate":0.06428},{"month":5,"riseRate":0.458333,"avgChangeRate":0.016725},{"month":6,"riseRate":0.375,"avgChangeRate":-0.019477},{"month":7,"riseRate":0.5,"avgChangeRate":0.013709},{"month":8,"riseRate":0.36,"avgChangeRate":-0.01606},{"month":9,"riseRate":0.24,"avgChangeRate":-0.02388},{"month":10,"riseRate":0.32,"avgChangeRate":-0.022373},{"month":11,"riseRate":0.5,"avgChangeRate":0.061425},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.0026}],"exchange":"SEHK","name":"长江生命科技","nameEN":"CKLIFE SCIENCES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长江生命科技,00775,长江生命科技股票,长江生命科技股票老虎,长江生命科技股票老虎国际,长江生命科技行情,长江生命科技股票行情,长江生命科技股价,长江生命科技股市,长江生命科技股票价格,长江生命科技股票交易,长江生命科技股票购买,长江生命科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长江生命科技(00775)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长江生命科技(00775)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}